To: Ms. Ursula von der Leyen
President of the European Commission

European Member States
Permanent Diplomatic Representations in Geneva

cc. Ambassador Dagfinn Sørli
Chair of the Council for TRIPS

29th June 2021

We, the undersigned, would like to express our serious concerns regarding the position of the European Commission on efforts to increase access to COVID-19 vaccines, treatments, and other medical goods by means of a temporary waiver of certain provisions of the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement.

For over a year, the pandemic has been ravaging societies and economies. Meanwhile, disparities in access to vaccines and other health technologies have resulted in uneven paths of recovery, with many countries yet to see any light at the end of the tunnel. The proposal from India and South Africa on a TRIPS waiver, submitted in October 2020, and the revised decision text presented in May, attempt to address inequities in access to critical commodities for controlling COVID-19. They do so by expeditiously facilitating freedom to scale up production and diversify supply options. This proposal is now co-sponsored by 63 World Trade Organization (WTO) Members and supported by more than 100 Members.

In the last nine months, the proposal has been discussed extensively and the co-sponsors have responded to questions and requests from WTO Members, including the European Union (EU). The proposal has received massive global support and is backed by United Nations agencies including the World Health Organization and UNAIDS, the scientific community, medical associations, trade unions, community and faith-based leaders, national and regional lawmakers, former presidents, prime ministers and Nobel laureates.

Within the EU, Member State legislatures in Spain, France and Italy have been vocal in supporting motions for a waiver at the WTO. Furthermore, the European Parliament recently approved a resolution “calling for support for proactive, constructive, and text-based negotiations for a temporary waiver of the WTO TRIPS Agreement, aiming to enhance global access to affordable COVID19- related medical products and to address global production constraints and supply shortages”[1].

On 4th June 2021, the European Commission submitted communication IP/C/W/680[2] to the Council for TRIPS titled “Urgent Trade Policy responses to the COVID-19 crisis: Intellectual Property”. This was followed by another communication on 18th June proposing a declaration on the TRIPS Agreement and Public Health in the circumstances of a pandemic (IP/C/W/681)[3].

The communications presented by the European Commission to the WTO are, in our view, devoid of any useful solutions, despite this being a critical point at which the WTO should be making decisive and concrete contribution to ensure timely, equitable global access to vaccines, treatments, diagnostics, and other COVID-19 health technologies and goods.

The clarifications contained in the communications are inadequate as they address issues that have never been in dispute and that are clearly provided for in the text of Article 31, and Article 31bis of the TRIPS Agreement and the Doha Declaration on TRIPS and Public Health.[4] These “pseudo-proposals” will create nothing but confusion and will simply serve to distract and delay discussion on the TRIPS waiver proposal.

The communications also fail to address the major underlying concern with respect to compulsory licensing – that its “case-by-case” or “product-by-product” approach is limiting during the pandemic and that this approach means additional tools are needed to overcome IP barriers.[5] In fact, historically the EU, the US and other high-income countries have discouraged developing countries from using compulsory licensing. Further, the requirements of Article 31bis of the TRIPS Agreement have rendered the mechanism unworkable to generally address access to medicines, even more so during a pandemic.

In addition, the communications’ focus on compulsory licensing is short-sighted in that it does not address the broader challenges posed by intellectual property rights, such as trade secrets, industrial designs and copyright that are needed to produce vaccines and other health technologies.

The disparity in access between high-income and lower-income countries is vast. Latest data shows that high-income countries that represent only 16% of the world population have fully vaccinated 28.5% of their populations, while a mere 0.1% of people in low-income countries and on average about 7.8% of middle-income countries have been fully vaccinated[6]. Similarly access to testing, therapeutics and other health technologies remains a challenge in developing countries. There is an urgent need to scale up and diversify production of vaccine and other critical technologies.

The EU’s communications cannot be considered as an alternative to the waiver proposal to address the pandemic access issues because they do not respond to any of the elements and concerns raised by the co-sponsors of the TRIPS waiver proposal and introduces text that may instead undermine the use of existing TRIPS flexibilities. In fact, we note that the TRIPS Waiver is based on a specific process under Article IX of the WTO.


To conclude:

  • We urge the EU Member States to request that the European Commission reconsiders its communications to the TRIPS Council given that they do not offer any meaningful solutions to the issue of equitable access and may instead undermine TRIPS flexibilitie


  • We demand that the EU does not disrupt the discussions on the TRIPS waiver proposa The EU must acknowledge the European Parliament’s opinion and constructively engage in the text-based negotiations of the TRIPS waiver proposal (IP/C/W/669/Rev.1), ensuring the will of European citizens and billions of people around the world is heard and realized.



Signatory organizations


International Organizations

  1. African Centre for Global Health & Social Transformation (ACHEST)
  2. Action against AIDS Germany
  3. ActionAid Nederland
  4. AIDS Action Europe
  5. Amnesty International
  6. APN+
  7. Asia Pacific Forum on Women, Law and Development
  8. Asian Health Institute
  9. Association for Proper Internet Governance
  10. Australian Arts Trust / Music Trust
  11. Brot füer die Welt
  12. BUKO Pharma-Kampagne
  13. Centre for Health and Resource Management
  14. CHISA
  16. Consiglio Nazionale delle Ricerche (Italy)
  17. Corporate Europe Observatory (CEO)
  18. COVID Advocates Advisory Board
  19. Development Alternatives with Women for a New Era (DAWN)
  20. Drug Action Forum – Karnataka
  21. East African Health Platform
  22. Education International
  23. European African Treatment Advocates Network
  24. European AIDS Treatment Group
  25. European Citizens’ Initiative No Profit on Pandemic
  26. European Federation of Public Service Unions (EPSU)
  27. Farmamundi
  28. Feminist Task Force
  29. Focus on the Global South
  30. Fondation Eboko
  31. Fondazione Lelio e Lisli Basso Onlus
  32. Foundation for Integrative AIDS Research (FIAR)
  33. Frontline AIDS
  34. Fundación Salud por Derecho
  35. Gandhi Development Trust
  36. GenderCC SA
  37. Global Health Advocates / Action Santé Mondiale
  38. Global People’s Health Movement
  39. Governance Links
  40. GRAIN
  41. Health Action International (HAI)
  42. Health Action International Asia Pacific
  43. Health Alliance International
  44. Health GAP
  45. HIV Legal Network (Canada)
  46. Human Rights Watch
  47. IFARMA Foundation
  48. Latin American Institute for La Paz and Citizenship (ILAPYC)
  49. IndustrialALL Global Union
  50. Institute for Agriculture and Trade Policy
  51. Institute for Economic Research on Innovation
  52. Interfaith Center on Corporate Responsibility
  53. International Federation of Anthroposophic Medical Associations
  54. International Treatment Preparedness Coalition (ITPC)
  55. International Union of Food, Agricultural,Hotel, Restaurant, Catering, Tobacco and Allied Workers Associations (IUF)g
  56. International Women’s Rights Action Watch Asia Pacific (IWRAW Asia Pacific)
  57. IT for Change
  59. Kazan Medical University
  60. KEI Europe
  61. Médecins du Monde
  62. Médecins Sans Frontières (MSF) Access Campaign
  63. Medical Mission Institute
  64. Medicina Democratica Onlus
  65. Medicusmundi
  66. NGO Santé Diabète
  67. Oxfam International
  68. Pan-African Treatment Access Movement
  69. Peoples Health Movement
  70. People’s Health Movement (PHM) Europe
  71. Pertubuhan Kebajikan Intan Zon Kehidupan
  72. Pharmaceutical Accountability Foundation
  73. PHM – Zambia
  74. PT Foundation
  75. Public Service International (PSI)
  76. Right2cure/Dirittoallacura Italia
  77. Salud y Fármacos
  78. Sisters of Charity Federation
  79. Society for International Development (SID)
  80. Solidarité Agissante pour Développement Familial (SADF)
  81. South Asia Alliance for Poverty Eradication (SAAPE)
  82. Southern African Programme on Access to Medicines and Diagnostics (SAPAM)
  83. The European Network against Commercialisation of Healthcare and Social Protection
  84. The Global Network of People living with HIV (GNP+)
  85. Third World Network
  86. Transnational Institute
  87. Transparency International Global Health
  88. Treatment Action Group
  89. UNI Global Union
  90. University College Dublin
  91. Viva Salud
  92. WeMove Europe
  93. Womankind Worldwide
  94. World Vision Deutschland e.V.
  95. Yolse, Santé Publique et Innovation

National Organizations

  1. Access to Medicines Ireland
  2. Acción Internacional para la Salud (AIS PERU)
  3. ActionAid Ireland
  4. ADSP-IB Associació per a la Defensa de la Sanitat Pública de les Illes Balears
  5. Africa Japan Forum
  6. Alianza por la Solidaridad-ActionAid
  7. Alliance Women of Advocating for Change (AWAC)
  8. All India Drug Action Network
  9. Ashar Alo Society
  10. Asociación de Mujeres Gente Nueva-AMUGEN
  11. Asociación por un Acceso Justo al Medicamento
  12. Associação Brasileira Interdisciplinar de AIDS (ABIA)
  13. Association de Lutte Contre la Dépendance
  14. Association For Promotion Sustainable Development
  15. Australian Fair Trade and Investment Network
  16. Belgia Center for Pharmacotherapeutical Information
  17. Bolivian Commitee for Consumers Protección CODEDCO
  18. Canadian Centre for Policy Alternatives (CCPA)
  19. Cancer Alliance, South Africa
  20. Coalition of Women Living with HIV and AIDS
  21. Center for Health, Human Rights and Development (CEHURD)
  22. Child Way Uganda
  23. CNCD-11.11.11
  24. Coalition for Health Promotion and Social Development (HEPS Uganda)
  25. Coalizione Italiana Libertà e i Diritti civili (CILD)
  26. COAST Trust
  27. Consumer Association the Quality of Life-EKPIZO
  28. Consumers’ Association of Penang
  29. Cooperative and Policy Alternative Center
  30. Coordinadora de Organizaciones para el Desarrollo
  31. Crisis Home
  32. Dandora Community Aids support Association (DACASA)
  33. Ecologistas en Acción
  34. Equidad de Género: Ciudadanía, Trabajo y Familia
  35. Fairwatch
  36. Federación de Asociaciones para la Defensa de la Sanidad Pública
  37. Focsiv Italian Federation Christian NGOs
  38. Forum Maranhense Das Respostas Comunitarias de Luta Contra as IST AIDS e Hepatites Virais
  39. Fórum ONG AIDAS RS
  40. Foundation for Male Engagement (FOME)
  41. Friends of the Earth Malaysia
  42. Fundación Grupo Efecto Positivo (FGEP)
  43. GeneEthics
  44. Gestos (soropositividade, comunicação, gênero)
  45. Grupo de Incentivo à Vida (GIV)
  46. Grandmothers Advocacy Network
  47. Grupo de Resistência Asa Branca- GRAB
  48. Grupo Pela Vidda SP
  49. Handel Anders Coalitie
  50. Health Equity Initiatives
  51. Indonesia AIDS Coalition
  52. Indonesia for Global Justice
  53. Initiative for Health & Equity in Society
  54. Innovations for Development (I4DEV)
  55. Integrated Social Development Effort (ISDE) Bangladesh
  56. International Community of Women Living with and affected by HIV- Kenya Chapter
  57. IPleft
  58. ItsOurFuture (NZ)
  59. Just Treatment
  60. Kamukunji Paralegal Trust (KAPLET)
  61. Kenya Legal & Ethical Issuse Network on HIV & AIDS
  62. Kenyan Network of Cancer Organizations
  63. Khulumani Support Group
  64. Konsil LSM Indonesia
  65. Korean Pharmacists for Democratic Society
  66. Malawi Health Equity Network
  67. Malawi Network of Religious Leaders Living with or Personally Affected by HIV and AIDS (MANERELA+)
  68. Malaysian Women’s Action for Tobacco Control and Health
  69. Milwaukee Fair Trade Coalition
  70. National Alliance of People’s Movements
  71. national Alliance of women Human Right defenders
  72. National Alliance of Women Human Rights Defenders (NAWHRD)
  73. National Fisheries Solidarity
  74. New Kashmir Women and Child Welfare Society
  75. Non-communicable Diseases Alliance Kenya
  76. Oxfam IBIS
  77. Pacifc Asia Resource Center (PARC)
  78. People’s Health Movement (PHM) Korea
  79. People’s Health Movement-Japan Circle
  80. Perkumpulan Medialink
  81. Perkumpulan PRAKARSA
  82. Pertubuhan Persaudaraan Pesawah Malaysia (PeSAWAH)
  83. PHM Kenya
  84. Positive Malaysian Treatment Access & Advocacy Group (MTAAG+)
  85. Positive Men’s Union (POMU)
  86. Public Citizen
  87. Red de Acceso a Medicamentos
  88. Rural Area Development Programme (RADP)
  89. Sankalp Rehabilitation Trust
  90. Southern and East African Trade Institute – South Africa (SEATINI)
  91. Servicios Ecumenicos para Reconciliation y Reconstruccion
  92. Sotsium Association
  93. Southern and Eastern African Trade Information and Negotiations Institute
  94. Sukaar Welfare Organization
  95. Tarangini Foundation
  96. TB Proof
  97. The Malaysian AIDS Council (MAC}
  98. The People’s Health Movement South Africa
  99. Trade Justice Network Canada
  100. Trade Justice Pilipinas
  101. Trade Justice Prince Edward Island
  102. Tusitukirewamu Group Bwaise
  103. UFRJ
  104. Uganda Key Populations Consortium Uganda (UKPC)
  105. University Health Network
  106. University of Naples Federico II
  107. We Rise and Prosper (WRAP)
  108. WEMOS
  109. Women’s Coalition Against Cancer- WOCACA
  110. Women’s Probono Initiative (WPI) – Uganda
  111. Zimbabwe National Network of PLHIV (ZNNP+)


[1] Texts adopted – Meeting the Global Covid-19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and increasing production and manufacturing capacity in developing countries – Thursday, 10 June 2021 (

[2] IP/C/W/680 (

[3] IP/C/W/681 (

[4] MSF analysis of EU communications to TRIPS Council on COVID -19 IP waiver proposal and “Disinformation, Diversion, and Delay: The Real Text of the European Union’s Communication to the WTO TRIPS Council” at

[5] Compulsory licenses, the TRIPS waiver and access to COVID-19 medical technologies waiver-and-access-covid-19-medical-technologies and MSF Technical Brief: Analysis of EU position on compulsory licensing and TRIPS waiver in the COVID-19 pandemic



MdM - TRIPS-vaccines - 5597